Health · 49 views
Researchers propose new target, repurposed drugs to make CAR T-cell therapy safer
CAR T-cell therapy has transformed cancer care, offering new hope to patients with aggressive blood cancers who once had few treatment options.
AI Summary
Researchers at UC Irvine have introduced a framework aimed at reducing the neurological toxicity associated with CAR T‑cell therapy, which can cause brain inflammation, confusion, seizures and other serious symptoms. The approach focuses on targeting the biological processes thought to underlie this complication, with the goal of making the treatment safer for patients with aggressive blood cancers. The work is detailed in a 2026 Pharmacology article (DOI: 10.3389/fphar.2026.1896516).
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Single blood protein stands out among 30 tests for assessing fatty liver diseaseContinue reading
- Do you know signs of a stroke? BE FAST are the words to rememberContinue reading
- Tumor index can identify breast cancer patients' drug responseContinue reading
- 'They're Looking for Scapegoats': What We Heard This WeekContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow